Literature DB >> 18510641

Baseline 6-min walk distance predicts survival in lung transplant candidates.

T Martinu1, M A Babyak, C F O'Connell, R M Carney, E P Trulock, R D Davis, J A Blumenthal, S M Palmer.   

Abstract

In a large, prospectively followed, two-center cohort of patients listed for lung transplantation (n = 376), we used Cox proportional hazards models to determine the importance of baseline 6-min walk distance (6MWD) in predicting patient survival. 6MWD used as a continuous variable was a significant predictor of survival after adjusting for other important covariates when transplant was considered as a time-varying covariate (HR for each 500 ft increase in 6MWD = 0.57, 95% CI: 0.43-0.77, p = 0.0002). 6MWD remained an important predictor of survival in models that considered only survival to transplant (HR for each 500 ft increase in 6MWD = 0.41, 95% CI: 0.27-0.62, p < 0.0001) or survival only after transplant (HR for each 500 ft increase in 6MWD = 0.40, 95% CI: 0.22-0.72, p = 0.002). Unadjusted Kaplan-Meier analysis demonstrates significantly different survival by 6MWD tertiles (<900, 900-1200, or >1200 ft, p-value = 0.0001). In the overall model, 6MWD prediction of survival was relatively homogeneous across disease category (6MWD by disease interaction term, p-value = 0.63). Our results demonstrate a significant relationship between baseline 6MWD and survival among patients listed for lung transplantation that exists across all native disease categories and extends through transplantation. The 6MWD is thus a useful measure of both urgency and utility among patients awaiting lung transplantation.

Entities:  

Mesh:

Year:  2008        PMID: 18510641      PMCID: PMC2714545          DOI: 10.1111/j.1600-6143.2008.02264.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  22 in total

1.  Impairments and prognostic factors for survival in patients with idiopathic pulmonary fibrosis.

Authors:  K Miki; R Maekura; T Hiraga; Y Okuda; T Okamoto; A Hirotani; T Ogura
Journal:  Respir Med       Date:  2003-05       Impact factor: 3.415

2.  Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis.

Authors:  Gabriel Thabut; Hervé Mal; Yves Castier; Odile Groussard; Olivier Brugière; Rolana Marrash-Chahla; Guy Lesèche; Michel Fournier
Journal:  J Thorac Cardiovasc Surg       Date:  2003-08       Impact factor: 5.209

3.  Confidence intervals for the effect of a prognostic factor after selection of an 'optimal' cutpoint.

Authors:  Norbert Holländer; Willi Sauerbrei; Martin Schumacher
Journal:  Stat Med       Date:  2004-06-15       Impact factor: 2.373

Review 4.  Dangers of using "optimal" cutpoints in the evaluation of prognostic factors.

Authors:  D G Altman; B Lausen; W Sauerbrei; M Schumacher
Journal:  J Natl Cancer Inst       Date:  1994-06-01       Impact factor: 13.506

5.  Outcome-oriented cutpoints in analysis of quantitative exposures.

Authors:  G Schulgen; B Lausen; J H Olsen; M Schumacher
Journal:  Am J Epidemiol       Date:  1994-07-15       Impact factor: 4.897

6.  Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience.

Authors:  J De Meester; J M Smits; G G Persijn; A Haverich
Journal:  J Heart Lung Transplant       Date:  2001-05       Impact factor: 10.247

7.  Assessment of survival benefit after lung transplantation by patient diagnosis.

Authors:  Susan C Charman; Linda D Sharples; Keith D McNeil; John Wallwork
Journal:  J Heart Lung Transplant       Date:  2002-02       Impact factor: 10.247

8.  Prognosis of patients with cystic fibrosis awaiting heart and lung transplantation.

Authors:  L Sharples; T Hathaway; C Dennis; N Caine; T Higenbottam; J Wallwork
Journal:  J Heart Lung Transplant       Date:  1993 Jul-Aug       Impact factor: 10.247

9.  Reference spirometric values using techniques and equipment that meet ATS recommendations.

Authors:  R O Crapo; A H Morris; R M Gardner
Journal:  Am Rev Respir Dis       Date:  1981-06

10.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

Authors:  Bartolome R Celli; Claudia G Cote; Jose M Marin; Ciro Casanova; Maria Montes de Oca; Reina A Mendez; Victor Pinto Plata; Howard J Cabral
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245

View more
  19 in total

1.  The utility of preoperative six-minute-walk distance in lung transplantation.

Authors:  Anthony W Castleberry; Brian R Englum; Laurie D Snyder; Mathias Worni; Asishana A Osho; Brian C Gulack; Scott M Palmer; R Duane Davis; Matthew G Hartwig
Journal:  Am J Respir Crit Care Med       Date:  2015-10-01       Impact factor: 21.405

2.  Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group.

Authors:  Michael T Durheim; Patrick J Smith; Michael A Babyak; Stephanie K Mabe; Tereza Martinu; Karen E Welty-Wolf; Charles F Emery; Scott M Palmer; James A Blumenthal
Journal:  Ann Am Thorac Soc       Date:  2015-03

3.  Relationship between pre-transplant physical function and outcomes after kidney transplant.

Authors:  Elizabeth C Lorenz; Andrea L Cheville; Hatem Amer; Brian R Kotajarvi; Mark D Stegall; Tanya M Petterson; Walter K Kremers; Fernando G Cosio; Nathan K LeBrasseur
Journal:  Clin Transplant       Date:  2017-04-17       Impact factor: 2.863

Review 4.  Lung transplantation in advanced COPD: is it worth it?

Authors:  Jamie L Todd; Scott M Palmer
Journal:  Semin Respir Crit Care Med       Date:  2010-05-21       Impact factor: 3.119

5.  Neurobehavioral functioning and survival following lung transplantation.

Authors:  Patrick J Smith; James A Blumenthal; Robert M Carney; Kenneth E Freedland; C Virginia F O'Hayer; Elbert P Trulock; Tereza Martinu; Todd A Schwartz; Benson M Hoffman; Gary G Koch; R Duane Davis; Scott M Palmer
Journal:  Chest       Date:  2014-03-01       Impact factor: 9.410

6.  Psychosocial Predictors of Mortality Following Lung Transplantation.

Authors:  P J Smith; J A Blumenthal; E P Trulock; K E Freedland; R M Carney; R D Davis; B M Hoffman; S M Palmer
Journal:  Am J Transplant       Date:  2015-09-14       Impact factor: 8.086

7.  Caregiver-assisted coping skills training for patients with COPD: background, design, and methodological issues for the INSPIRE-II study.

Authors:  James A Blumenthal; Francis J Keefe; Michael A Babyak; C Virginia Fenwick; Julie M Johnson; Kylie Stott; Rachel K Funk; Meredith J McAdams; Scott Palmer; Tereza Martinu; Don Baucom; Philip T Diaz; Charles F Emery
Journal:  Clin Trials       Date:  2009-04       Impact factor: 2.486

Review 8.  Lung transplantation at Duke.

Authors:  Alice L Gray; Michael S Mulvihill; Matthew G Hartwig
Journal:  J Thorac Dis       Date:  2016-03       Impact factor: 2.895

9.  Pre-transplant weight loss and clinical outcomes after lung transplantation.

Authors:  Emily Siu Clausen; Courtney Frankel; Scott M Palmer; Laurie D Snyder; Patrick J Smith
Journal:  J Heart Lung Transplant       Date:  2018-07-29       Impact factor: 10.247

10.  A 1-Month Physical Therapy-Based Outpatient Program for Adults Awaiting Lung Transplantation: A Retrospective Analysis of Exercise Capacity, Symptoms, and Quality of Life.

Authors:  Rebecca Byrd; Patrick Smith; Omar Mohamedaly; Laurie D Snyder; Amy M Pastva
Journal:  Cardiopulm Phys Ther J       Date:  2019-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.